Ann Mccormack

Biography

Dr McCormack completed her PhD studies at the Kolling Institute of Medical Research examining the role of MGMT (06-methylguanine-DNA methyltransferase) as a biomarker of response to temozolomide (a novel therapy for aggressive pituitary tumours) and exploring its role in pituitary tumorigenesis. She was awarded the 2008 Endocrine Society of Australia Bryan Hudson Clinical Endocrinology Award and has been invited to present her work at the 2009 American Endocrine Society Annual Scientific Meeting and 2012 International Congress of Endocrinology in Italy. During 2010, she also undertook a research and clinical fellowship at the Oxford Centre for Diabetes, Endocrinology and Metabolism in the UK, a centre with an international reputation for expertise in pituitary disease and neuroendocrine tumours. She has recently been awarded the 2013 John Shine Translational Research Fellowship at the Garvan Institute. Dr McCormack also holds a 3 year tenure as Chair of the Program Organising Committee for the Endocrine Society of Australia’s Annual Scientific Meeting. Dr McCormack is a staff specialist in the Department of Endocrinology at St Vincent’s Hospital and holds a conjoint position at the Garvan Institute of Medical Research and The University of New South Wales. Her primary research interest is in the field of pituitary tumour biology, in particular aggressive pituitary tumours and familial pituitary tumours.

Research Interest

Pituitary tumorigenesis Familial pituitary tumour genetics Genomic profiling of pituitary tumours Hormonal regulation of cancer development and progression